Literature DB >> 411928

Pulmonary damage associated with sodium aurothiomalate therapy.

P W Gould, P L McCormack, D G Palmer.   

Abstract

Three patients with rheumatoid arthritis developed acute respiratory distress associated with pulmonary infiltration, during treatment with sodium aurothiomalate. This manifestation of gold toxicity has only recently been recognized. The temporal relationship to the introduction of gold therapy, an exacerbation following further gold injection in one patient, the resolution which followed gold withdrawal and the associated manifestation of gold toxicity in two patients favored a diagnosis of gold-induced pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 411928

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

Review 1.  Adverse reactions with oral and parenteral gold preparations.

Authors:  E C Tozman; N L Gottlieb
Journal:  Med Toxicol       Date:  1987 May-Jun

2.  Gold lung.

Authors:  D W James; W F Whimster; E B Hamilton
Journal:  Br Med J       Date:  1978-06-10

3.  Fatal intrahepatic cholestasis and interstitial lung fibrosis following gold therapy for rheumatoid arthritis.

Authors:  M R Shaban; D N Golding; R G Letcher
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

4.  Gold-induced lung disease.

Authors:  J Heyd; A Simmeran
Journal:  Postgrad Med J       Date:  1983-06       Impact factor: 2.401

5.  Fatal bronchiolitis obliterans associated with chrysotherapy.

Authors:  L Holness; J Tenenbaum; N B Cooter; R F Grossman
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

6.  Relationship of gold and penicillamine therapy to diffuse interstitial lung disease.

Authors:  D L Scott; G V Bradby; T J Aitman; G C Zaphiropoulos; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

7.  Pulmonary damage with gold or penicillamine.

Authors:  A Bamji; N Cooke
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

8.  Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.

Authors:  H J Williams; J R Ward; M J Egger; J C Reading; C O Samuelson; M Altz-Smith; R W Willkens; M A Solsky; S P Hayes; D Furst
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

Review 9.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

10.  Fatal, gold-induced pneumonitis.

Authors:  M Jose Soler; Encarnacion Barroso; F Ignacio Aranda; Sergio Alonso; Santiago Romero
Journal:  Rheumatol Int       Date:  2003-03-13       Impact factor: 3.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.